Eagle Bay Advisors LLC

SEC CIK: 0001862864
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by Eagle Bay Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overview All 13F holders of ADAPY Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of ADAPY by Eagle Bay Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−3,388−100.0%	Sold out	Holders
Q4 2021	3,388	$15.0K	<0.1%	−492−12.7%	Reduced	Holders
Q3 2021	3,880	$20.0K	<0.1%	+3,880	New	Holders